Cardiovascular consequences of sleep apnea: I -Epidemiology

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 1, 2010, Pages 75-80

  Çelen, Yelda Turgut ^a   Peker, Yüksel ^a,b  

^a SKARABORG HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Epidemiology; Obstructive sleep apnea

Indexed keywords

AGE DISTRIBUTION; BLOOD PRESSURE; BODY MASS; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL SLEEP APNEA SYNDROME; CHEYNE STOKES BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; FAMILY HISTORY; GENDER; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LUNG ARTERY PRESSURE; LUNG DISEASE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; PULMONARY HYPERTENSION; RESTENOSIS; REVIEW; SLEEP APNEA SYNDROME; SMOKING; ST SEGMENT ELEVATION; SUDDEN DEATH; TACHYCARDIA;

ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; CHEYNE-STOKES RESPIRATION; CORONARY DISEASE; HEART FAILURE; HUMANS; HYPERTENSION; HYPERTENSION, PULMONARY; METABOLIC SYNDROME X; OBESITY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; TACHYCARDIA;

EID: 76649105739     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Young T, Palta M, Dempsey J, Skatrud S, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328: 1230-5.
2. Peker Y, Hedner J, Norum J Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002; 166: 159-65.
3. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease. J Am Coll Cardiol 2008; 52: 686-717.
4. Marshall NS, Wong KKH, Liu PY, Cullen SRJ, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: The Busselton Health Study. Sleep 2008; 31: 1079-85.
5. Young T, Finn L, Peppard P, Szklo-Coxe M, Austin D, Nieto FJ, et al. Sleep-disordered-breathing and mortality: Eighteen-year followup of the Wisconsin Sleep Cohort. Sleep 2008; 31: 1071-8.
6. Marti S, Sampol G, Munoz X, Torres F, Roca A, Lloberes P, et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002; 20: 1511-8.
7. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive Sleep Apnea as a Risk Factor for Stroke and Death. N Engl J Med 2005; 353: 2034-41.
8. Peker Y, Hedner J, Kraiczi H, Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000; 162: 81-6.
9. Fletcher, E. C., R. D. DeBehnke, M. S. Lovoi, A. B. Gorin. Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 1985; 103: 190-5.
10. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001; 19: 2271-7.
11. Baguet JP, Hammer L, Levy P, Pierre H, Rossini H, Mouret S. Nighttime and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005; 23: 521-7.
12. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. Blood pressure 'dipping' and 'non¬dipping' in obstructive sleep apnea syndrome patients. Sleep 1996; 19: 382-7.
13. Hla KM, Young T, Finn L, Peppard PE, Szklo-Coxe M, Stubbs M. Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep cohort Study. Sleep 2008; 31: 795-800.
14. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378-84.
15. Drager LF, Pereira AC, Barreto-Filho JA, Figueiredo AC, Krieger JE, Krieger EM. Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea. J Hum Hypertens 2006; 20: 523-6.
16. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-87.
17. Atwood CW, McCrory D, Garcia JG, Abman SH, Ahearn GS. Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 72-7.
18. Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5-12.
19. Hedner J, Franklin K, Peker Y. Obstructive sleep apnea and coronary artery disease. In: Kryger, Roth, Dement, editors. Principals and Practice of Sleep Medicine. 4th ed. Philadelphia, PA: Elsevier Inc; 2005. p. 1203-7.
20. Mooe T, Franklin KA, Wiklund U, Rabben T, Holmström K. Sleepdisordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 2000; 117: 1597-602.
21. De Araújo CM, Solimene MC, Grupi CJ, Genta PR, Lorenzi-Filho G, Da Luz PL. Evidence that the degree of obstructive sleep apnea may not increase myocardial ischemia and arrhythmias in patients with stable coronary artery disease. Clinics 2009; 64: 223-30.
22. Hayashi M, Fujimoto K, Urushibata K, Imamura H, Kinoshita O, Kubo K. Nocturnal oxygen desaturation as a predictive risk factor for coronary restenosis after coronary intervention. Circ J 2005; 69: 1320-6.
23. Nakashima H, Katayama T, Takagi C, Amenomori K, Ishizaki M, Honda Y, et al. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J 2006; 27: 2317-22.
24. Steiner S, Schueller PO, Hennersdorf MG, Behrendt D, StrauerBE. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res 2008; 9: 50.
25. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 2007; 99: 26-30.
26. Valham F, Mooe T, Rabben T, Stenlund H, Wiklund U, Franklin KA. Increased risk of stroke in patients with coronary artery disease and sleep apnea: a 10-year follow-up. Circulation 2008; 118: 955-60.
27. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006; 28: 596-602.
28. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001; 163: 19-25.
29. Gami AS, Rader S, Svatikova A, Wolk R, Herold DL, Huyber C, et al. Familial premature coronary artery disease mortality and obstructive sleep apnea. Chest 2007; 131: 118-21.
30. Harbison J, O'Reilly P, McNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest 2000; 118: 591-5.
31. Becker H, Brandenburg U, Peter JH, Von Wichert P. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995; 151: 215-8.
32. Garrigue S, Pepin JL, Defaye P, Murgatroyd F, Poezevara Y, Clementy J. High prevalence of sleep apnea syndrome in patients with longterm pacing: the European Multicenter Polysomnographic Study. Circulation 2007; 115: 1703-9.
33. Mehra R, Benjamin EJ, Sharar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173: 910-6.
34. Serizawa N, Yumino D, Kajimoto K, Tagawa Y, Takagi A, Shoda M, et al. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol 2008; 102: 1064-8.
35. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005; 352: 1206-14.
36. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110: 364-7.
37. Javaheri S, Parker TJ, Wexler L, Liming JD, Lindower P, Roselle GA, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure-types and their prevalences, consequences, and presentations. Circulation 1998; 97: 2154-9.
38. Mooe T, Gullsby S, Rabben T. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Dis 1996; 7: 475-8.
39. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102: 61-6.
40. Yoneyama K, Osada N, Shimozato T, Ishibashi Y, Hayashi A, Takahashi E, et al. Relationship between sleep-disordered breathing level and acute onset time of congestive heart failure. Int Heart J 2008; 49: 471-80.
41. Roebuck T, Solin P, Kaye DM, Bergin P, Bailey M, Naughton MT, et al. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 2004; 23: 735-40.
42. Dursunoglu D, Dursunoglu N, Ozkurt S, Tanriverdi H, Evrengül H, Kiter G. Impact of obstructive sleep apnoea on left ventricular mass and global function. Eur Respir J 2005; 26: 283-8.
43. Fung JW, Li TS, Choy DK, Yip GW, Ko FW, Sanderson JE, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002; 121: 422-9.
44. Tugcu A, Guzel D, Yildirimturk O, Aytekin S. Evaluation of right ventricular systolic and diastolic function in patients with newly diagnosed obstructive sleep apnea syndrome without hypertension. Cardiology 2009; 113: 184-92.
45. Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007; 49: 1625-31.
46. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Medicine 2009; 6: e1000132.
47. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005; 25: 514-20.
48. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046-53.
49. Jarvik ME. Beneficial effects of nicotine. Br J Addict 1991; 86: 571-5.
50. Davila DG, Hurt RD, Offord KP, Harris CD, Shepard JW Jr. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am J Respir Crit Care Med 1994; 150: 469-74.
51. Lavie L, Lavie P. Smoking interacts with sleep apnea to increase cardiovascular risk. Sleep Med 2008; 9: 247-53.
52. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983; 67: 968-77.
53. Grunstein RR, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obesity 1993; 17: 533-40.
54. Grunstein RR, Stenlöf K, Hedner J, Sjöström L. Impact of obstructive sleep apnea and sleepiness on metabolic and cardiovascular risk factors in the Swedish Obese Subjects (SOS) Study. Int J Obesity 1995; 19: 410-8.
55. Laaban JP, Cassuto D, Orvoen-Frija E, Iliou MC, Mundler O, Leger D, et al. Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity. Eur Respir J 1998; 11: 20-7.
56. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004; 25: 735-41.
57. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middleaged and overweight men. Am J Respir Crit Care Med 2002; 165: 677-82.
58. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE. Sleep Heart Health Study Investigators. Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004; 160: 521-30.
59. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-9.
60. Shaw JE, Punjabi NM, Wilding JP, Alberti KG, Zimmet PZ. Sleepdisordered breathing and type 2 diabetes. A report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. Diabetes research and clinical practice 2008; 81: 2-12.